The primary objective of this review was to systematically identify
and map topical therapies used for the management of pain
associated with malignant fungating wounds (MFWs). For the purposes of
this review, topical therapy was defined as the application of
a product directly to the wound bed and the surrounding
periwound skin, in accordance with the definition provided by Mayba
and Gooderham (2018).